CX3CR1 Deficiency Confers Protection From Intimal Hyperplasia ...

2062 Arterioscler Thromb Vasc Biol. September 2006
10. Ghilardi G, Biondi ML, Turri O, Guagnellini E, Scorza R. Internal carotid
artery occlusive disease and polymorphisms of fractalkine receptor
CX3CR1: a genetic risk factor. Stroke. 2004;35:1276–1279.
11. Harrison JK, Jiang Y, Wees EA, Salafranca MN, Liang HX, Feng L,
Belardinelli L. Inflammatory agents regulate in vivo expression of fractalkine
in endothelial cells of the rat heart. J Leukoc Biol. 1999;66:
937–944.
12. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ,
Raines EW. Tumor necrosis factor-alpha-converting enzyme (ADAM17)
mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol
Chem. 2001;276:37993–38001.
13. Tsou CL, Haskell CA, Charo IF. Tumor necrosis factor-alpha-converting
enzyme mediates the inducible cleavage of fractalkine. J Biol Chem.
2001;276:44622–44626.
14. Fong AM, Robinson LA, Steeber DA, Tedder TF, Yoshie O, Imai T, Patel
DD. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte
capture, firm adhesion, and activation under physiologic flow. J Exp Med.
1998;188:1413–1419.
15. Haskell CA, Cleary MD, Charo IF. Molecular uncoupling of fractalkinemediated
cell adhesion and signal transduction. Rapid flow arrest of
CX3CR1-expressing cells is independent of G-protein activation. J Biol
Chem. 1999;274:10053–10058.
16. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M,
Kakizaki M, Takagi S, Nomiyama H, Schall TJ, Yoshie O. Identification
and molecular characterization of fractalkine receptor CX3CR1, which
mediates both leukocyte migration and adhesion. Cell. 1997;91:521–530.
17. Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR.
Smooth muscle cells in human atherosclerotic plaques express the fractalkine
receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine
fractalkine (CX3CL1). Circulation. 2003;108:2498–2504.
18. Wong BW, Wong D, McManus BM. Characterization of fractalkine
(CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis,
diabetes mellitus, and transplant vascular disease. Cardiovasc
Pathol. 2002;11:332–338.
19. Schafer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M,
Ertl G, Walter U, Bauersachs J. Novel role of the membrane-bound
chemokine fractalkine in platelet activation and adhesion. Blood. 2004;
103:407–412.
20. Chandrasekar B, Mummidi S, Perla RP, Bysani S, Dulin NO, Liu F,
Melby PC. Fractalkine (CX3CL1) stimulated by nuclear factor kappaB
(NF-kappaB)-dependent inflammatory signals induces aortic smooth
muscle cell proliferation through an autocrine pathway. Biochem J. 2003;
373:547–558.
21. Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Yan ZQ,
Weber C. Neointimal smooth muscle cells display a proinflammatory
phenotype resulting in increased leukocyte recruitment mediated by
P-selectin and chemokines. Circ Res. 2004;94:776–784.
22. Roque M, Fallon JT, Badimon JJ, Zhang WX, Taubman MB, Reis ED.
Mouse model of femoral artery denudation injury associated with the
rapid accumulation of adhesion molecules on the luminal surface and
recruitment of neutrophils. Arterioscler Thromb Vasc Biol. 2000;20:
335–342.
23. Roque M, Kim WJ, Gazdoin M, Malik A, Reis ED, Fallon JT, Badimon
JJ, Charo IF, Taubman MB. CCR2 deficiency decreases intimal hyperplasia
after arterial injury. Arterioscler Thromb Vasc Biol. 2002;22:
554–559.
24. Smyth SS, Reis ED, Zhang W, Fallon JT, Gordon RE, Coller BS.
Beta(3)-integrin-deficient mice but not P-selectin-deficient mice develop
intimal hyperplasia after vascular injury: correlation with leukocyte
recruitment to adherent platelets 1 hour after injury. Circulation. 2001;
103:2501–2507.
25. Schober A, Zernecke A, Liehn EA, von Hundelshausen P, Knarren S,
Kuziel WA, Weber C. Crucial role of the CCL2/CCR2 axis in neointimal
hyperplasia after arterial injury in hyperlipidemic mice involves early
monocyte recruitment and CCL2 presentation on platelets. Circ Res.
2004;95:1125–1133.
26. Gear AR, Camerini D. Platelet chemokines and chemokine receptors:
linking hemostasis, inflammation, and host defense. Microcirculation.
2003;10:335–350.
27. Clemetson KJ, Clemetson JM, Proudfoot AE, Power CA, Baggiolini M,
Wells TN. Functional expression of CCR1, CCR3, CCR4, and CXCR4
chemokine receptors on human platelets. Blood. 2000;96:4046–4054.
28. Weingartner O, Kasper M, Reynen K, Bramke S, Marquetant R, Sedding
DG, Braun-Dullaeus R, Strasser RH. Comparative morphometric and
immunohistological assessment of the development of restenosis after
arterial injury and a cholesterol-rich diet in apolipoprotein E -/-mice and
C57BL/6 control mice. Coron Artery Dis. 2005;16:391–400.
29. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS,
Virmani R. Pathology of acute and chronic coronary stenting in humans.
Circulation. 1999;99:44–52.
30. Reidy MA, Fingerle J, Lindner V Factors controlling the development of
arterial lesions after injury. Circulation. 1992;86:III43–III46.
31. Schwartz RS Pathophysiology of restenosis: interaction of thrombosis,
hyperplasia, and/or remodeling. Am J Cardiol. 1998;81:14E–17E.
32. Cercek M, Matsumoto M, Li H, Chyu KY, Peter A, Shah PK, Dimayuga
PC. Autocrine role of vascular IL-15 in intimal thickening. Biochem
Biophys Res Commun. 2006;339:618–623.
33. Cambien B, Pomeranz M, Schmid-Antomarchi H, Millet MA,
Breittmayer V, Rossi B, Schmid-Alliana A. Signal transduction pathways
involved in soluble fractalkine-induced monocytic cell adhesion. Blood.
2001;97:2031–2037.
34. Shulby SA, Dolloff NG, Stearns ME, Meucci O, Fatatis A. CX3CR1fractalkine
expression regulates cellular mechanisms involved in
adhesion, migration, and survival of human prostate cancer cells. Cancer
Res. 2004;64:4693–4698.
35. Ollivier V, Faure S, Tarantino N, Chollet-Martin S, Deterre P, Combadiere
C, de Prost D. Fractalkine/CX3CL1 production by human aortic
smooth muscle cells impairs monocyte procoagulant and inflammatory
responses. Cytokine. 2003;21:303–311.
36. Streblow DN, Soderberg-Naucler C, Vieira J, Smith P, Wakabayashi E,
Ruchti F, Mattison K, Altschuler Y, Nelson JA. The human cytomegalovirus
chemokine receptor US28 mediates vascular smooth muscle cell
migration. Cell. 1999;99:511–520.
Downloaded from
http://atvb.ahajournals.org/ by guest on March 25, 2013